MKAD-21 Suppresses the Oncogenic Activity of the miR-21/PPP2R2A/ERK Molecular Network in Bladder Cancer

JOURNAL ARTICLE published 1 July 2018 in Molecular Cancer Therapeutics

Authors: Marina Koutsioumpa | Hsiao-Wang Chen | Neil O'Brien | Filippos Koinis | Swapna Mahurkar-Joshi | Christina Vorvis | Artin Soroosh | Tong Luo | Shawnt Issakhanian | Allan J. Pantuck | Vassilis Georgoulias | Dimitrios Iliopoulos | Dennis J. Slamon | Alexandra Drakaki